Premium
[P4–589]: CNS DRUG‐LIKE INHIBITORS OF TAU OLIGOMERIZATION
Author(s) -
Moe James G.,
Gluchowski Charles,
Krishnamurthy Pavan K.,
Davidowitz Eliot J.
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.07.752
Subject(s) - chemistry , lead compound , tau protein , in vivo , pharmacokinetics , long term potentiation , drug discovery , polar surface area , pharmacology , biophysics , neuroscience , biochemistry , in vitro , molecule , alzheimer's disease , biology , medicine , receptor , pathology , disease , microbiology and biotechnology , organic chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom